Bharat Biotechs Covaxin vaccine is approved for emergency use for 2 to 18 years olds by The Subject Expert Committee.
Highlights
In September, the phase 2 and 3 trials of Covaxin happed, and reports were submitted to the Drugs and Comptroller General of India (DCGI) in October.
The trials suggested that the safety and immunity of the Covaxin are almost as same in children aged 2-18 years, as it is in adults above 18-years of age.
The Covaxin, also known as BBV15, is an inactivated virus-based COVID-19 vaccine developed by Bharat Biotech with the Indian Council of Medical Research (Icmr).